亚洲精品无码久久久久苍井空,办公室全肉高H湿play视频,亚洲AV无码成人片在线观苍井空,粉嫩AV一区二区三区在线,人妻91无码色偷偷色噜噜噜

中文
中文

以患者需求為核心，驅(qū)動細胞免疫治療創(chuàng)新，實現(xiàn)癌癥可控化并最終治愈。

We strive to make patients-driven cellular immunotherapy innovation, to transform cancer into a manageable condition — and ultimately cure it.

科學論文
SCIENTIFIC PUBLICATION
  • 03.232022
    2018
    Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 9(1):5361. (*: Corresponding authors, PMCID: PMC6299138)Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y.,
  • 03.232022
    Dr. Qi-Jing Li’s Publication
    Dr. Li has published more than 100 papers on Cell, Cancer Cell, Nature, Nature Immunology, Immunity, EMBO, and Nature Communication, etc. His publications have been cited for more than 9000 times. Below are some selected papers with significant impacts in the scientific field.
  • 03.232022
    Dr. Pin Wang’s Publication
    Dr. Wang has published more than 80 papers on Nature Biotechnology, Cell Stem Cell, PNAS, Nature Communication, ACS Nano, and Molecular Therapy, etc. He has also filed more than 10 patents as lead inventor or co-inventor. Below are some selected papers and patents with significant impacts in the scientific field.
12
查看更多

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號

 粵ICP備20056630號 Powered by vancheer
關于天科雅
研究與發(fā)展
產(chǎn)品及臨床
新聞與媒體

Copyright ? 2019 天科雅生物醫(yī)藥科技有限公司

粵公網(wǎng)安備 44011502000528號

 粵ICP備20056630號 Powered by vancheer